Sorry, this website is not ready for mobile preview. Make sure to check on Desktop for now.
Services
Avian Services
Testing
IgY Antibodies
Custom Biologics
View all services
Antibody Discovery & Development
Overview
Tool Generation
Immunization
Antibody Discovery
Antibody Characterization
Developability Profiling
Optimization & Engineering
Cell Line Development
Protein Production & Purification
Preclinical Testing
View all services
Products
Avian Products
Avian Biologicals
SPF Eggs
SPF Chickens
Chicken Cell Products
View Catalog
Avian Products
Avian Antigens
Avian Antisera
Mycoplasma & Pullorum Plate Antigens
Human Influenza Virus
Sendai Virus
View all products
Antibodies & Proteins
Organoid Research
Inflammatory Diseases
General Research Tools
Cell Biology
Complement & Innate Immunity
Hematology
Infectious Diseases
Molecular Cell Biology
Oncology
View all products
Applications
Company
About
Careers
News & Press
Let's talk
Menu
News & Press
News & Press
•
February 17, 2026
RoukenBio and AVS Bio Announce Strategic Partnership to Integrate Design-Focused Antibody Discovery and Optimization with Mechanism-Driven Functional Characterization
Learn more
News & Press
•
September 11, 2025
IPA Europe Rebrands as AVS Bio, Marking Next Phase of Growth
Learn more
News & Press
•
August 6, 2025
AVS Bio, an Arlington Capital Partners Portfolio Company, Expands Antibody Discovery and Protein Production Capabilities With Acquisition of ImmunoPrecise Antibodies Europe From ImmunoPrecise Antibodies Ltd.
Learn more
News & Press
•
July 11, 2023
AVS Bio Appoints Jac Price as Chief Executive Officer to Expand Bioprocessing Platform
Learn more